Trileptal and Drop attacks - a phase IV clinical study of FDA data

Summary:

Drop attacks is reported as a side effect among people who take Trileptal (oxcarbazepine), especially for people who are female, 2-9 old, have been taking the drug for 5 - 10 years also take Topamax, and have Arthritis.

The phase IV clinical study analyzes which people have Drop attacks when taking Trileptal. It is created by eHealthMe based on reports of 22,012 people who have side effects when taking Trileptal from the FDA, and is updated regularly.

What is Trileptal?

Trileptal has active ingredients of oxcarbazepine. It is often used in bipolar disorder. eHealthMe is studying from 23,558 Trileptal users. Check the latest studies of Trileptal.

What is Drop attacks?

Drop attacks (sudden spontaneous falls while standing or walking) is found to be associated with 146 drugs and 236 conditions by eHealthMe. Check the latest studies of Drop attacks.

On Jul, 14, 2026

22,012 people reported to have side effects when taking Trileptal.
Among them, 30 people (0.14%) have Drop attacks.

Among these 30 people:

How long have people been on Trileptal when they have Drop attacks? *

What is the gender of people who have Drop attacks when taking Trileptal? *

female: 53.85 %
male: 46.15 %

What is the age of people who have Drop attacks when taking Trileptal? *

What are other drugs people take besides Trileptal? *

What are other side effects people have besides Drop attacks? *

Memory Loss: 21 people, 70.00%
Dizziness: 21 people, 70.00%
Fatigue (feeling of tiredness): 21 people, 70.00%
Dyspnea (difficult or laboured breathing): 21 people, 70.00%
Rashes (redness): 20 people, 66.67%
Headache (pain in head): 20 people, 66.67%
Stress And Anxiety: 20 people, 66.67%
Fainting (loss of consciousness and postural tone): 17 people, 56.67%
Dehydration (dryness resulting from the removal of water): 17 people, 56.67%
Fistula (an abnormal connection or passageway between two): 16 people, 53.33%

What are the existing conditions these people have? *

Sleep Disorder: 16 people, 53.33%
Nausea (feeling of having an urge to vomit): 16 people, 53.33%
Muscle Spasms (muscle contraction): 16 people, 53.33%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 16 people, 53.33%
Depression: 16 people, 53.33%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 16 people, 53.33%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 6.67%
Temporal Lobe Epilepsy (a term that refers to a condition where seizures are generated in the portion of the brain called the temporal lobe): 1 person, 3.33%
Petit Mal Epilepsy (absence seizure): 1 person, 3.33%
Folate Deficiency (lack of folic acid): 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Trileptal and have Drop attacks?

- Check whether Drop attacks is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Trileptal:

Trileptal (23,558 reports)

Drop attacks treatments and more:

Drop attacks (789 reports)

Browse all side effects of Trileptal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drop attacks:

Drop attacks (146 drugs)

Browse all the conditions that are associated with Drop attacks:

Drop attacks (236 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oxcarbazepine (the active ingredients of Trileptal) and Trileptal (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.